Type 2 Diabetes Modifies Skeletal Muscle Gene Expression Response to Gastric Bypass Surgery
IntroductionRoux-en-Y gastric bypass (RYGB) is an effective treatment for type 2 diabetes mellitus (T2DM) that can result in remission of clinical symptoms, yet mechanisms for improved skeletal muscle health are poorly understood. We sought to define the impact of existing T2DM on RYGB-induced muscl...
Main Authors: | Matthew D. Barberio, G. Lynis Dohm, Walter J. Pories, Natalie A. Gadaleta, Joseph A. Houmard, Evan P. Nadler, Monica J. Hubal |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.728593/full |
Similar Items
-
Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome.
by: Loqmane Seridi, et al.
Published: (2018-01-01) -
Comparison of visceral adipose tissue DNA methylation and gene expression profiles in female adolescents with obesity
by: Matthew D. Barberio, et al.
Published: (2019-11-01) -
Outcomes of Roux-en-Y gastric bypass surgery for severely obese patients with type 1 diabetes: a case series report
by: Tanenberg RJ, et al.
Published: (2010-08-01) -
Type 2 diabetes remission after Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric surgery study
by: Marziyeh Moradi, et al.
Published: (2022-10-01) -
Treatment challenges in type 1 diabetes after roux-en-Y gastric bypass
by: Lucie Favre, et al.
Published: (2017-03-01)